Sign Up Today and Learn More About Nested Therapeutics Stock
Invest in or calculate the value of your shares in Nested Therapeutics or other pre-IPO companies through EquityZen's platform.
![Nested Therapeutics](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/nestedtherapeutics_logo-677bf4827741555e.jpg)
Nested Therapeutics Stock
Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.
About Nested Therapeutics Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Nested Therapeutics Press Mentions
Stay in the know about the latest news on Nested Therapeutics
Inductive Bio Announces Publication of Successful Drug Optimization Collaboration with Nested Therapeutics
prnewswire • Aug 02, 2024
Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs ...
biospace • Jun 25, 2024
Nested Therapeutics Announces Oral Presentation of Preclinical Data for NST-628, a Novel, Fully Brain-Penetrant, Pan ...
prnewswire • May 19, 2024
Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs ...
prnewswire • May 19, 2024
Mitogen-activated protein kinase (mek) inhibitors
patents • Apr 13, 2024
Nested Therapeutics Management
Leadership team at Nested Therapeutics
Board Member
Carlo Rizzuto
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Nested Therapeutics current valuation
- Nested Therapeutics stock price
- Available deals in Nested Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Nested Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Nested Therapeutics through EquityZen funds. These investments are made available by existing Nested Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Nested Therapeutics stock?
Shareholders can sell their Nested Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."